Content area
Full text
Strativa Pharmaceuticals, the proprietary products division of Par Pharmaceuticals, announced the addition of Jim Jones, MD, as chief medical officer. Jones brings 21 years of pharmaceutical experience to Strativa, including a long history of direct involvement in all aspects of drug development in both large and small pharmaceutical companies. Most recently, Jones served as VP, clinical development and medical affairs for Xanodyne Pharmaceuticals, Inc. Prior to that, he served as VP, clinical development for Alpharma Pharmaceuticals. Jones spent the earlier part of his career at Pharmacia/Pfizer, Novartis, Sanofi-Aventis and Guilford/ MGI Pharma.